Important Alert
2021 ASCRS Annual Meeting: Important announcement
Registration is Open
Registration and Housing for the 2021 ASCRS ASOA Annual Meeting is Open!
The ASCRS ASOA 2021 Annual Meeting is the largest U.S. event dedicated to the needs of anterior segment surgeons. Registration for the meeting – being held July 23-27, 2021 at the Mandalay Bay Convention Center in Las Vegas, Nevada – is now open.
ASCRS Cornea Day
Program
Fri
Jul 23, 2021
8:05 - 9:35. A.M.
Session 1: Challenging Cornea Cases
Moderators: Brandon Ayres, MD and Karolinne Rocha, MD
8:05 - 8:14 A.M.
Central and practical corneal perforation
8:15 - 8:24 A.M.
Big and Bad Bacteria: Infectious Keratitis
8:25 - 8:34 A.M.
Fungal Keratitis
8:35 - 8:44 A.M.
Discussion Q&A
8:45 - 8:54 A.M.
Medical and Surgical Management of PUK
8:55 - 9:04 A.M.
Ocular Surface Tumors: OSSN and Melanoma
9:05 - 9:14 A.M.
Scleritis
9:15 - 9:24 A.M.
Non Healing Corneal Ulcers (NK)
9:50 - 11:40 A.M.
Session II: Anterior/Posterior Lamellar Surgery
Moderators: W. Barry Lee, MD; Ken Beckman, MD
Anterior lamellar surgery
9:50- 9:52 A.M.
Welcome
9:53 - 10:00 A.M.
Barriers to DALK
10:01 - 10:18 A.M.
Panel Discussion
10:19 - 10:26 A.M.
Crosslinking Update - Epi on Epi Off
10:27 - 10:34 A.M.
Techniques of Lamellar Patch Grafts
10:35 - 10:44
Panel Discussion
Posterior Lamellar Surgery
10:45 - 10:52 A. M.
Management of Fungal Keratitis in EK Interface
10:52 - 11:02 A.M.
Panel Discussion
11:03 - 11:10 A.M.
Injectable Endothelial Cells
11:11 - 11:20 A.M.
Panel Discussion
11:21 - 11:28 A.M.
EK in Complicated Cases
11:29 - 11:38 A.M.
Panel Discussion
12:40 - 2:35 P.M.
Session III: Ocular Surface
Moderators: Clara Chan, MD; Marjan Farid, MD
Part 1: Updates in Lid Margin Disease Management
12:40 - 12:42 P.M.
Welcome Back
12:43 - 12:52 P.M.
Clinical Findings and Diagnosis of Lid Margin Disease (Meibography)
12:53 - 1:02 P.M.
Medical Treatments: Oral Tetracyclines, Nutraceuticals/Omega 3FA, at Home Treatments
1:03 - 1:12 P.M.
Procedural Treatments
1:13 - 1:17 P.M.
Q&A
1:18 - 1:25 P.M.
Inflammation and the Role of Steroids in DED
1:26 - 1:33 P.M.
Emerging Treatments in DED and Neuropathic Pain
1:34 - 1:38 P.M.
Panel Discussion and Q&A
Part 2: Controversies and Management of Severe Ocular Surface Disease
1:39 - 1:48 P.M.
Clinical Findings and Medical Management of Severe Ocular Surface Disease
1:49 - 1:53 P.M.
Case 1 - Unilateral LSCD from Alkali Burn: SLET vs. ClAU
1:54 - 1:58 P.M.
Case 1 Discussion
1:59 - 2:03 P.M.
Case 2-SJA Patient with Servere Ocular Surface Disease: Ocular Surface Reconstruction with KLAL/LR-CLAL and Immunosuppression vs. Primary KPro
2:04 - 2:08 P.M.
Case Dicussion
2:09 - 2:13 P.M.
Case 3 - Total LSCD in Young Anirida Patient - Primary KPro or KLAL with Immunosuppression
2:19 - 2:23 P.M.
Case 4- Diffuse LSCD - Primary PKP or Ocular Surface Reconstructions First
2:19 - 2:23 P.M.
Case 4 Discussion
2:24 - 2:28 P.M.
Case 5 - Multiple Failed Grafts/Rejections - Another PKP or Kpro
2:29 - 2:33 P.M.
Case 5 Discussion
2:50 - 4:30 P.M
Session IV: Perspectives... Where We Were and Where We're Going...
Moderators: Francis Mah, MD; Edward Holland, MD
History of Keratoplasty
Eyebanking - For profit or not for profit - A point/counterpoint discussion
Reimbursement Issues
Alternatives for Keratoplasty
Pro's and con's of Kpro; DWEK/DSEO; Artificial cornea
Best methods to diagnose and show progression of Keratoconus
Management of “culture negative,” atypical appearing corneal ulcer
